{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Naringin", "cancer", "cardiovascular diseases", "gastrointestinal tract disorders", "naringenin", "naringin formulations", "neurodegenerative diseases", "pharmacokinetics", "pulmonary disorders", "type 2 diabetes mellitus"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "32496985", "DateCompleted": {"Year": "2021", "Month": "05", "Day": "21"}, "DateRevised": {"Year": "2022", "Month": "01", "Day": "07"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": ["10.2174/0929867327666200604171351"], "Journal": {"ISSN": "1875-533X", "JournalIssue": {"Volume": "28", "Issue": "10", "PubDate": {"Year": "2021"}}, "Title": "Current medicinal chemistry", "ISOAbbreviation": "Curr Med Chem"}, "ArticleTitle": "New Perspectives in the Pharmacological Potential of Naringin in Medicine.", "Pagination": {"StartPage": "1987", "EndPage": "2007", "MedlinePgn": "1987-2007"}, "Abstract": {"AbstractText": ["Naringin (NAR) is a flavonoid enriched in several medicinal plants and fruits. An increasing interest in this molecule has emerged because it has the potential to contribute to alleviating many health problems.", "This review briefly describes the NAR pharmacokinetics and it mainly focuses on the in vitro and in vivo animal studies showing NAR beneficial effects on cardiovascular, metabolic, neurological and pulmonary disorders and cancer. The anabolic effects of NAR on different models of bone and dental diseases are also analyzed. In addition, the evidence of the NAR action on the gastrointestinal tract is reported as well as its influence on the microbiota composition and activity. Finally, current research on NAR formulations and clinical applications are discussed.", "The PubMed database was searched until 2019, using the keywords NAR, naringenin, cardiovascular and metabolic disorders, neurological and pulmonary disorders, cancer, bone and dental diseases, gastrointestinal tract, microbiota, NAR formulations, clinical trials.", "The number of studies related to the bioavailability and pharmacokinetics of NAR is limited. Positive effects of NAR have been reported on cardiovascular diseases, Type 2 Diabetes Mellitus (T2DM), metabolic syndrome, pulmonary disorders, neurodegenerative diseases, cancer, and gastrointestinal pathologies. The current NAR formulations seem to improve its bioavailability, which would allow its clinical applications.", "NAR is endowed with broad biological effects that could improve human health. Since a scarce number of clinical studies have been performed, the NAR use requires more investigation in order to know better their safety, efficacy, delivery, and bioavailability in humans."], "CopyrightInformation": "Copyright\u00a9 Bentham Science Publishers; For any queries, please email at epub@benthamscience.net."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratorio \"Dr. Fernando Canas\", Catedra de Bioquimica y Biologia Molecular, Facultad de Ciencias Medicas, INICSA (CONICET-Universidad Nacional de Cordoba), Pabellon Argentina, 2do. Piso, Ciudad Universitaria, 5000 Cordoba, Argentina."}], "LastName": "Rivoira", "ForeName": "Mar\u00eda Ang\u00e9lica", "Initials": "MA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratorio \"Dr. Fernando Canas\", Catedra de Bioquimica y Biologia Molecular, Facultad de Ciencias Medicas, INICSA (CONICET-Universidad Nacional de Cordoba), Pabellon Argentina, 2do. Piso, Ciudad Universitaria, 5000 Cordoba, Argentina."}], "LastName": "Rodriguez", "ForeName": "Valeria", "Initials": "V"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratorio \"Dr. Fernando Canas\", Catedra de Bioquimica y Biologia Molecular, Facultad de Ciencias Medicas, INICSA (CONICET-Universidad Nacional de Cordoba), Pabellon Argentina, 2do. Piso, Ciudad Universitaria, 5000 Cordoba, Argentina."}], "LastName": "Talamoni", "ForeName": "Germ\u00e1n", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratorio \"Dr. Fernando Canas\", Catedra de Bioquimica y Biologia Molecular, Facultad de Ciencias Medicas, INICSA (CONICET-Universidad Nacional de Cordoba), Pabellon Argentina, 2do. Piso, Ciudad Universitaria, 5000 Cordoba, Argentina."}], "LastName": "Tolosa de Talamoni", "ForeName": "Nori", "Initials": "N"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "United Arab Emirates", "MedlineTA": "Curr Med Chem", "NlmUniqueID": "9440157", "ISSNLinking": "0929-8673"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Flavanones"}, {"RegistryNumber": "0", "NameOfSubstance": "Flavonoids"}, {"RegistryNumber": "N7TD9J649B", "NameOfSubstance": "naringin"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": [], "DescriptorName": "Biological Availability"}, {"QualifierName": [], "DescriptorName": "Diabetes Mellitus, Type 2"}, {"QualifierName": [], "DescriptorName": "Flavanones"}, {"QualifierName": [], "DescriptorName": "Flavonoids"}, {"QualifierName": [], "DescriptorName": "Fruit"}, {"QualifierName": [], "DescriptorName": "Humans"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2020", "Month": "2", "Day": "11"}, {"Year": "2020", "Month": "4", "Day": "22"}, {"Year": "2020", "Month": "4", "Day": "24"}, {"Year": "2020", "Month": "6", "Day": "5", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "5", "Day": "22", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "6", "Day": "5", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["32496985", "10.2174/0929867327666200604171351", "CMC-EPUB-107112"]}}]}